Zentalis Pharmaceuticals, Inc.

Q4 2022 13F Holders

Symbol
ZNTL
CUSIP
98943L107
Type
Equity
Class
COM
Num filings
112
Total reported value, excl. options
$1.36 B
Manager Report Date Value ($000) Shares Option Type